You watched
Dear buyers! Unfortunately, we are currently unable to accept the application to Canada and are revoking the license. Keep an eye on the site to see if there are any updates from Canada.
Catalog
Client
Currency:
Contacts
Our location:
Ternopil city
Contacts
E-mail
We are on social networks
Go to contacts
0 0
Catalog
Main page
Viewed
7
Wishlist
0
Compare
0
Contacts

Menopur lyophilized powder for preparation of solution for injection 75 IU bottle with solvent in ampoules 1 ml No. 10

SKU: an-10219
0
All about product
Description
Specification
Reviews 0
Questions0
new
Menopur lyophilized powder for preparation of solution for injection 75 IU bottle with solvent in ampoules 1 ml No. 10
In Stock
7 809.00 грн.
Active ingredient:Menotropin
Adults:Can
ATC code:G AGENTS AFFECTING THE GENITORY SYSTEM AND SEX HORMONES; G03 SEX GLAND HORMONES AND PREPARATIONS USED IN PATHOLOGY OF THE GENITAL SPHERE; G03G GONADOTROPINS AND OTHER STIMULATORS OF OVULATION; G03G A Gonadotropin hormones; G03G A02 Human menopausal gonadotropin
Country of manufacture:Czech Republic
Diabetics:Can
Delivery
USPS across the USA USPS across the USA
Canada Post across Canada Canada Post across Canada
Payment
Menopur lyophilized powder for preparation of solution for injection 75 IU bottle with solvent in ampoules 1 ml No. 10
7 809.00 грн.
Description

Lyophilized powder for solution for injection Menopur is indicated for the following indications:

Female infertility due to anovulation (including polycystic ovary syndrome (PCOS)) in women who are not amenable to treatment with clomiphene citrate. In controlled ovarian hyperstimulation for the induction of multiple follicular formation as part of assisted reproductive technologies (ART).

Composition

Active ingredient: 1 vial contains menotropin (highly purified LMH, LMH), containing follicle-stimulating hormone (FSH) 75 IU and luteinizing hormone (LH) 75 IU;

Excipients: lactose, polysorbate 20, sodium hydroxide, hydrochloric acid;

Solvent: 0.9% sodium chloride solution, diluted hydrochloric acid, water for injections.

Contraindication

Menopur is contraindicated in the following conditions:

Pituitary or hypothalamic tumors; carcinoma of the ovaries, uterus or mammary glands; pregnancy and breastfeeding; gynecological bleeding of unknown etiology; hypersensitivity to the active substance or to any of the excipients included in the preparation; ovarian enlargement or ovarian cysts not associated with polycystic ovary syndrome.

Method of application

Treatment with Menopur should be initiated under the supervision of a physician experienced in the treatment of reproductive disorders.

Menopur is intended for subcutaneous or intramuscular use. The powder should be reconstituted immediately before administration using the solvent provided. Up to 3 vials of Menopur powder can be reconstituted in 1 ml of solvent. DO NOT shake. The solution should be used if it contains particles or is opaque.

The dosage regimens are identical for subcutaneous and intramuscular administration.

Application features

Pregnant women

Contraindicated.

Children

Do not use on children.

Overdose

The effects of overdose are unknown, ovarian hyperstimulation syndrome may develop. Treatment is symptomatic.

Side effects

The most commonly observed side effects were: ovarian hyperstimulation syndrome (OHSS), abdominal pain, headache, bloating, and pain at the injection site.

Interaction

When used in combination with gonadotropin-releasing factor agonists for pituitary desensitization, high doses of Menopur may be required to achieve the desired ovarian response.

Storage conditions

Store at a temperature not exceeding 25 °C in a place protected from light, out of the reach of children.

Do not use the drug after the expiration date indicated on the package.

The shelf life of the powder is 2 years.

The shelf life of the solvent is 3 years.

Specifications
Characteristics
Active ingredient
Menotropin
Adults
Can
ATC code
G AGENTS AFFECTING THE GENITORY SYSTEM AND SEX HORMONES; G03 SEX GLAND HORMONES AND PREPARATIONS USED IN PATHOLOGY OF THE GENITAL SPHERE; G03G GONADOTROPINS AND OTHER STIMULATORS OF OVULATION; G03G A Gonadotropin hormones; G03G A02 Human menopausal gonadotropin
Country of manufacture
Czech Republic
Diabetics
Can
Dosage
75 МО
Drivers
No data on exposure
For allergies
With caution
For children
It is impossible.
Form
Vials with dry contents
Method of application
Injections
Nursing
It is impossible.
Pregnant
It is impossible.
Primary packaging
bottle
Producer
Ferring
Trade name
Menopur
Vacation conditions
By prescription
Reviews

There are no reviews for this product.

There are no reviews for this product, be the first to leave your review.

Answers & questions
Add your question and we will answer as soon as possible.

No questions about this product, be the first and ask your question.

You are watched
new
BABE Laboratorios Anti-Hair Loss Lotion 125 ml
In stock
0
1 057.00 грн.
new
Dr.Sante Cannabis Hair Hair Spray 150 ml
In stock
0
147.06 грн.
new
Zolmigren film-coated tablets 2.5 mg No. 10
In stock
0
503.65 грн.
new
Sold out
Ginkgo biloba-F capsules 0.4 g No. 60
Распродано
0
181.50 грн.
new
Eucerin Anti-Pigment Tag Day Cream SPF 30 50 ml
In stock
0
1 019.57 грн.
new
Silicone teether Lindo TN 007
In stock
0
98.71 грн.
new
Breast pads Canpol Babies 18/602 premium small #2
In stock
0
179.62 грн.